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Fatty acid transfer from intestinal fatty acid-binding protein 
(IFABP) to phospholipid membranes occurs during protein-mem­
brane collisions. Electrostatic interactions involving the ^-helical 
“portal” region of the protein have been shown to be of great impor­
tance. In the present study, the role of specific lysine residues in the 
^-helical region of IFABP was directly examined. A series of point 
mutants in rat IFABP was engineered in which the lysine positive 
charges in this domain were eliminated or reversed. Using a fluores­
cence resonance energy transfer assay, we analyzed the rates and 
mechanism of fatty acid transfer from wild type and mutant pro­
teins to acceptor membranes. Most of the ^-helical domain mutants 
showed slower absolute fatty acid transfer rates to zwitterionic 
membranes, with substitution of one of the lysines of the ^2 helix, 
Lys27, resulting in a particularly dramatic decrease in the fatty acid 
transfer rate. Sensitivity to negatively charged phospholipid mem­
branes was also reduced, with charge reversal mutants in the ^2 
helix the most affected. The results support the hypothesis that the 
portal region undergoes a conformational change during protein­
membrane interaction, which leads to release of the bound fatty 
acid to the membrane and that the ^2 segment is of particular 
importance in the establishment of charge-charge interactions 
between IFABP and membranes. Cross-linking experiments with a 
phospholipid-photoactivable reagent underscored the importance 
of charge-charge interactions, showing that the physical interaction 
between wild-type intestinal fatty acid-binding protein and phos­
pholipid membranes is enhanced by electrostatic interactions. Pro­
tein-membrane interactions were also found to be enhanced by the 
presence of ligand, suggesting different collisional complex struc­
tures for holo- and apo-IFABP.
Intestinal fatty acid-binding protein (IFABP)2 34 belongs to a family of 
intracellular lipid binding proteins of low molecular mass (14 –15 kDa) 
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with the putative general function of lipid trafficking (1). The precise 
physiological functions of these proteins are as yet unclear, but it is 
hypothesized that they are important in intracellular transport and tar­
geting of FA to specific membranous organelles and metabolic path­
ways. Intestinal fatty acid-binding protein is abundantly produced in the 
enterocyte, where a second fatty acid-binding protein (FABP), liver 
FABP (LFABP), is also highly expressed (2). It is not known why a single 
cell type contains two distinct types of FABP nor whether one or both 
participate in the intracellular trafficking and compartmentation of 
lipid. A number of differences between the two enterocyte FABPs, in 
binding specificity and stoichiometry and in ligand transport properties, 
suggest unique functional properties (1, 3, 4). To address the putative 
transport function of the FABPs, we have used an in vitro fluorescence 
resonance energy transfer assay to examine the rate and mechanism of 
transfer of fluorescently tagged fatty acids from FABPs to phospholipid 
membranes. These studies have demonstrated that transfer of fatty 
acids from IFABP to membranes appears to occur during direct colli­
sional interactions between the protein and the acceptor membrane (3). 
In contrast, LFABP employs a different FA transfer mechanism, involv­
ing an initial release of the ligand to the aqueous milieu prior to its 
membrane association (5). As discussed previously (3, 6), we hypoth­
esize that “collisional” fatty acid transfer by IFABP may be necessary 
for specific targeting of this physiologically important lipid. More­
over, it is also possible that IFABP forms charge-charge interactions 
with acidic domains on membrane proteins, thereby facilitating the 
targeted transport of intracellular fatty acids. In addition, the abso­
lute rate of fatty acid transfer by IFABP-membrane interaction is 
dramatically increased relative to off-rates for fatty acids from 
FABPs into solution, supporting the idea of greater efficiency of fatty 
acid trafficking via the collisional mechanism.
Fatty acid-binding proteins share a common tertiary structure con­
sisting of 10 antiparallel ^-strands that form a ^-barrel, which is capped 
by two short ^-helices arranged as a helix-turn-helix segment. It is 
believed that this helical domain is part of a “dynamic portal” that 
regulates fatty acid (FA) entry and exit from the internal binding 
cavity (7, 8). The structural elements underlying collisional transfer of 
a fatty acid from IFABP to membranes could have important physiolog­
ical consequences, since they may dictate the fatty acid trafficking pat­
terns within the cell. Using a helixless variant of IFABP (9) and employ­
ing chimeric proteins generated by exchanging the helix-turn-helix 
domains between IFABP and LFABP, we have demonstrated that the 
^-helical region of IFABP plays a primary role in the collisional transfer 
of fatty acid from IFABP to membranes (8, 10) and that this domain 
determines the unique FA transfer mechanism from LFABP or IFABP
methyl-(3H)-diazirin-3-yl)benzyl]oxy]carbonyl]nonanoyl]-sn-glycero-3-phosphocho- 
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FIGURE 1. Ribbon diagram of rat intestinal FABP derived from 2.0 Å resolution x-ray 
crystallography (20) (Protein Data Bank code 2IFB). Lys16, Lys20, Lys27, Lys29, and 
Lys92 have been highlighted in a stick representation. The protein molecule is oriented to 
show the positions of mutated residues.
to acceptor membranes (4).5 Abundant experimental evidence has indi­
cated that electrostatic interactions are a major determinant of the 
mechanism of FA transfer from all of the “collisional” proteins of this 
family (adipocyte, heart, brain, myelin, and intestinal FABPs) (11–16). 
In addition, an analysis of surface electrostatic potential topologies for 
several FABPs demonstrated a net positive potential across the helix­
turn-helix portal region of “collisional transfer” FABPs (17), which sup­
ports the suggestion that this region is important for interactions with 
membranes. It is noteworthy that the ^1 helices of IFABP, heart FABP, 
and adipocyte FABP are amphipathic, whereas ^1 helices of LFABP, 
liver basic FABP, and cellular retinoid-binding protein II, which do not 
employ a collisional ligand transfer mechanism, are not (18). 
Amphipathic helices are known to be important motifs in the targeting 
of proteins to membranes, and the charge characteristics of a helix are 
believed to modulate interactions with membranes (19).
5 G. R. Franchini, B. Co´ rsico, and J. Storch, unpublished observations.
In the present study, we tested the hypothesis that the lysine residues 
of the ^-helical domain of IFABP play an important role in the collision­
based transfer of FA to membranes. Several pairs of point mutants of 
IFABP were engineered so as to neutralize or reverse the positive charge 
of the lysines present in the ^-helical domain (Lys16, Lys20, Lys27, and 
Lys29) as well as Lys92 in the ^-barrel (Fig. 1). The primary objectives of 
this work were to determine whether the elimination of positively 
charged residues in the ^-helical domain of IFABP would alter the rate 
and, potentially, the mechanism of transfer of FA from the mutant pro­
teins to membranes, compared with the wild-type IFABP (wtIFABP), 
and to assess the relative contributions of each of the charged residues.
A fluorescence resonance energy transfer assay was used to assess the 
kinetics of FA transfer from FABPs to membranes, and direct interac­
tion of the IFABPs with phospholipid membranes was determined using 
a cross-linking assay with vesicles containing a photoactivable reagent. 
The results demonstrate that no single lysine was solely responsible for 
the FA transfer properties of IFABP. Rather, all of the Lys residues of the 
^-helical domain contribute to the collisional mechanism of FA transfer 
from IFABP to model membranes. Lys residues of the ^2 segment are of 
particular importance in the FA transfer process.
EXPERIMENTAL PROCEDURES
Materials
The mutagenic primers were obtained from Invitrogen (Carlsbad, 
CA). Pfu DNA polymerase, pGEM-T easy vector, and restriction 
enzymes XbaI and BamHI were purchased from Promega (Madison, 
WI). T4 DNA ligase, pET-11a expression vector, and BL21 (DE3) cells 
were obtained from Novagen (Milwaukee, WI). Sodium oleate was 
obtained from Nu-Chek Prep (Elysan, MN). Fluorescently labeled 
AOFA, 12-(9-anthroyloxy)oleic acid (12AO), and acrylodated IFABP 
(ADIFAB) were purchased from Molecular Probes, Inc. (Eugene, OR). 
Egg phosphatidylcholine (EPC), N-(7-nitro-2,1,3-benzoxadiazol-4-yl) egg 
phosphatidylcholine (NBD-PC), brain phosphatidylserine (PS), and bovine 
heart cardiolipin (CL) were obtained from Avanti Polar Lipids (Alabaster, 
AL). Lipidex-1000 was purchased from Sigma. Isopropyl-^-D-thiogalacto- 
side was obtained from Fisher. [125I]NaI was from PerkinElmer Life Sci­
ences. All other chemicals were reagent grade or better.
Construction of Point Mutant IFABPs
IFABP has four lysine residues in the helix-turn-helix domain, two in 
each ^-helical segment. A series of point mutants were constructed 
substituting lysine for isoleucine to eliminate the charge and lysine for 
glutamic acid to reverse the charge. Isoleucine and glutamic acid were 
chosen to replace lysine due to their respective neutral and negative 
charges and the relatively similar bulkiness to lysine, so as to maintain 
the approximate side chain size along the backbone of the protein. Thus, 
eight mutations in the ^-helical region were constructed, and an addi­
tional pair of mutants, K92I and K92E, was also generated to assess the 
effects of a nonhelix domain basic residue; Lys92 is located in ^strand G. 
Recombinant rat pET11d-IFABP plasmid was generously provided by 
Drs. Alan Kleinfeld and Ron Ogata (Medical Biology Institute, La Jolla, 
CA). A single or double mutation was introduced in the IFABP 
sequence employing overlapping PCR methodology (20). The same 
external primers were used for all constructs: 5^-CGGATAACAAT- 
TCCCCTCTA-3^ and 5^-TTCCTTTCGGGCTTTGTTAG-3^. Each 
mutation was verified by sequence analysis. Mutant DNA sequences 
were subcloned into the pET-11a expression vector by using XbaI and 
BamHI restriction sites.
Protein Expression and Purification
All proteins were overexpressed in Escherichia coli BL21 DE3 har­
boring pET constructs for wild-type and point mutant proteins, as 
detailed elsewhere (3, 8); all of the proteins were found in the soluble 
fraction of the bacterial lysates and were purified from E. coli as 
described previously (3, 8).
Analysis of Wild-type and Mutant FABPs
None of the lysine residues mutated in this study are found within the 
ligand binding site (21); thus, maintenance of binding site integrity was 
expected. To assess this directly, the overall conformation and ligand 
binding site properties of the mutant IFABPs were examined by several 
methods.
Molecular Modeling—Crystallographic structures of rat apo-IFABP 
(Protein Data Bank code 1IFC) (21) and rat holo-IFABP with palmitate 
bound (Protein Data Bank code 2IFB) (22), solved at 2.0 and 1.2 Å, 
respectively, were used to model the mutant proteins. Silicon Graphics 
workstations running the InsightII program (Accelrys, San Diego, CA) 
were used to replace amino acids to generate initial models, one single 
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site replacement for each mutant protein. We then performed confor­
mational energy minimization, first adding hydrogens to the structures, 
since the Protein Data Bank files contained heavy atoms only. The mod­
eling pH was set to 7.4. The “soak” facility of InsightII was used to create 
a layer of water molecules around the protein 5.0 Å thick. Water mole­
cules present in the crystallographic files were retained prior to “soak­
ing” as well as the bound palmitate in the holo structure. The energy was 
then minimized to convergence using default settings. The wild type 
molecules in the PDB files were also minimized in order that compari­
sons between wild type and mutants would compare structures that had 
been treated identically. Bond lengths, bond angles, and Ramachandran 
plots were normal (data not shown). Analysis of solvent-accessible sur­
face area was by the method of Lee and Richards (23) using the program 
ACCESS (24). The ACCESS output was sorted and compiled by BINS 
(25), which classifies each atom as to whether it is aliphatic, aromatic, 
polar uncharged, or polar charged and aggregates the results for each 
amino acid and for the protein as a whole. Volumes were computed by 
the Voronoi method with the program VOLUME, the output being 
compiled by VOLFMT (26, 27).
CD Spectra—CD spectra were obtained at 25 °C on an Aviv model 
60DS spectropolarimeter using a 0.1-cm path length quartz cuvette 
(Hellma). Spectra of the wild-type and mutant proteins were obtained 
from five scans between 200 and 260 nm of a 0.15 mg/ml protein con­
centration solution to evaluate shape, ellipticity, and maximum and 
minimum positions.
Fluorescent Quantum Yields—Fluorescent quantum yields (Qf) of 
12-(9-anthroyloxy)oleic acid (12AO) bound to wild-type and mutant 
IFABPs were determined using quinine sulfate in 0.1 N H2SO4 as the 
reference fluorophore, with Qref ^ 0.7 (28). Excitation was at 352 nm for 
quinine sulfate and 383 nm for 12AO.
Binding of Oleate—Binding of oleate to wild-type and mutant IFABPs 
was analyzed by the method employing the fluorescent probe ADIFAB 
(29), which allows for the direct measurement of unbound fatty acid in 
equilibrium with FABP. Oleate prepared as a 25 mM stock solution of 
the sodium salt in water at pH 9.7 containing 25 ^M BHT was titrated 
into 2.5 ml of 10 mM HEPES, 150 mM NaCl, 5 mM KCl, and 1 mM 
Na2HPO4 (pH 7.4) containing 0.2 ^M ADIFAB and 4 ^M wild type or 
mutant IFABP. Following equilibration at 37 °C for 5 min, fluorescence 
emission intensities at 505 and 432 nm were measured using an SLM- 
8000C spectrofluorometer, with excitation at 386 nm. The average and 
S.D. of 10 pairs of R (emission 505 nm/emission 432 nm) values were 
determined. This average was applied to binding equilibrium analysis 
using a standard value of Rmax ^ 11.5 (29). Experimental values were 
fitted to a single-site Scatchard analysis, and Kd values for oleate binding 
were obtained.
Relative Partition Coefficient—The relative partition coefficient (Kp) 
for AOFA partitioning between wild type or mutant IFABPs and small 
unilamellar vesicles (SUVs) was determined by measuring AOFA fluo­
rescence at a given molar ratio of protein/SUV after titration of SUV 
into a solution containing 5 ^M protein and 0.5 ^M 12AO in 40 mM Tris, 
100 mM NaCl, pH 7.4 (TBS) at25°C (30, 31).
([FABP-bound AOFA]/[FABP]) 
Kp ^ ([SUV-bound AOFA]/[SUV]) (Eq. 1)
The decrease in AOFA fluorescence upon titration of AOFA-con- 
taining FABP with SUVs was related to Kp by the following equation,
1/^F ^ 1/Kp(1/^Fmax)([FABP]/[SUV]) ^ 1/^Fmax (Eq.2)
where ^F is the difference between the initial fluorescence of AOFA in 
the FABP and the AOFA fluorescence at a given protein/SUV ratio, and 
^Fmax is the maximum difference in AOFA fluorescence. A plot of 1/^F 
versus (1/^Fmax)([SUV]/[FABP]) gives a slope of 1/Kp. The partition 
coefficient was used to establish AOFA transfer assay conditions so as to 
ensure essentially unidirectional transfer, as detailed below (32).
Vesicle Preparation for AOFA Transfer Experiment
SUVs were prepared by sonication and ultracentrifugation as described 
previously (33, 34). The standard vesicles were prepared to contain 90 mol 
% of EPC and 10 mol % of NBD-PC, which served as the fluorescent 
quencher. To increase the negative charge density of the acceptor vesicles, 
either 25 mol % of PS or CL were incorporated into the SUVs in place of an 
equimolar amount of EPC. Vesicles were prepared in TBS buffer except for 
SUVs containing cardiolipin, which were prepared in TBS with 1 mM 
EDTA.
Transfer of AOFA from FABP to SUV
A fluorescence resonance energy transfer assay was used to mon­
itor the transfer of AOFA from the wild type and mutant IFABPs to 
acceptor model membranes as described in detail elsewhere (3, 4, 8). 
Briefly, FABP with bound AOFA was mixed at 25 °C with SUV using 
a stopped-flow spectrofluorometer DX-17MV (Applied Photophys­
ics Ltd.). The NBD moiety is an energy transfer acceptor of the 
anthroyloxy group donor; therefore, the fluorescence of the AOFA is 
quenched when the ligand is bound to SUVs that contain NBD-PC. 
Upon mixing, transfer of AOFA from protein to membrane is 
directly monitored by the time-dependent decrease in anthroyloxy 
group fluorescence. Final transfer assay conditions were 15 ^M wild­
type or mutant IFABP with 1.5 ^M 12AO and a range of 150–600^M 
SUV. Controls to ensure that photobleaching was eliminated were 
performed prior to each experiment, as previously described (8). 
Data were analyzed using software provided with the instrument, 
and all curves were well described by a single exponential function. 
For each experimental condition within a single experiment, at least 
five replicates were done. Average values ^ S.D. for three or more 
separate experiments are reported, unless otherwise indicated.
Preparation of Photoactivable Reagents
125I-TID-PC was prepared by radioiodination of its nonradioactive 
tin-containing precursor 1-O-hexadecanoyl-2-O-[9-[[[2-(tributylstannyl)- 
4-(trifluoromethyl-(3H)-diazirin-3-yl)benzyl]oxy]carbonyl]nonanoyl]-sn- 
glycero-3-phospho-choline according to Weber and Brunner (35) and 
our previous work (36). The precursor was generously donated by Prof. 
J. Brunner from the Swiss Federal Institute of Technology (Zurich, Swit­
zerland). The dried tin-containing precursor (^20 nmol) was dissolved 
in 10 ^l of acetic acid in a 1-ml Reacti-Vial (Pierce). [125I]NaI (1 mCi) 
was added, and the iodination was started by the addition of peracetic 
acid (2 ^l of a 32% solution in acetic acid). After 2 min at room temper­
ature, the reaction was quenched with 50 ^lof10%Na2S2O5. Then 40 ^l 
of chloroform/methanol (2:1) were added and vortexed. The organic 
phase was collected and concentrated using a charcoal filter to adsorb 
volatile radioactivity. The residue was dissolved in 20 ^l of methanol/ 
chloroform/H2O (9:1:1) and subjected to reverse-phase high pressure 
liquid chromatography using the same solvent and a 208HS54 C8 col­
umn (Vydac) in a Merck-Hitachi apparatus with UV detection at 254 
nm. The flow rate was 1 ml/min, and fractions of 0.5 ml were collected. 
125I-TID-PC eluted at ^20 min, whereas the excess of tin-containing 
precursor eluted at ^40 min. An aliquot (5 ^l) of each fraction in the 
elution region of 125I-TID-PC was analyzed by TLC on silica gel plates 
(LK6D, 60 Å; Whatman, Clifton, NJ) and subjected to autoradiography.
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TABLE 1
Energy minimization and physical and binding parameters of wild-type and mutant IFABPs
Conformational energy minimization was performed on wild type and mutant proteins (modeled from crystallographic structures) employing the Insight II program as 
described under “Experimental Procedures.” Expressed wild type and mutant IFABP were analyzed for circular dichroism spectroscopic properties (^222), apparent ligand 
disociation constants (Kd), coefficients for AOFA partitioning (Kp) between SUVs and FABPs, and fluorescent quantum yields (Qf), as outlined under “Experimental 
Procedures.” ND, not determined. Results for Kd, Kp, and Qf are the average of three separate experiments ^ S.D. except those indicated with an asterisk.
Energy
^222 Kd Kp QfApo Holo
kcal/mol degrees M^1 cm^1 nM [SUV]/[prot]
wtIFABP ^15,304 ^12,027 ^5265 37 ^ 1 12.5 ^ 5.7 0.08 ^ 0.02
K16I ^15,302 ^11,934 ^9026 45 ^ 1 21.8 ^ 5.9 0.08 ^ 0.03
K16E ^15,418 ^12,064 ND 32 ^ 6 13* 0.08 ^ 0.02
K20I ^15,227 ^12,251 ^7662 40 ^ 7 18.5 ^ 0.7 0.11 ^ 0.04
K20E ^15,359 ^12,012 ^9883 41 ^ 16 20* 0.11 ^ 0.03
K27I ^15,333 ^12,005 ^9887 35 ^ 3 11.8 ^ 4.0 0.14 ^ 0.04
K27E ^15,425 ^12,035 ND 57 ^ 2 14.7* 0.07 ^ 0.02
K29I ^15,302 ^12,017 ^8683 28* 19.1* 0.15 ^ 0.04
K29E ^15,429 ^12,122 ^4583 21* 14.5* 0.18 ^ 0.05
K92I ^15,176 ^11,934 ^4994 49* ND 0.12 ^ 0.07
K92E ^15,209 ^12,058 ^5839 61* 9.5* 0.13 ^ 0.07
Fractions containing radioactivity were pooled and concentrated by co­
evaporation with toluene/ethanol (1:1). 125I-TID-PC was dissolved in 
ethanol/toluene (1:1) at ^1 mCi/ml and stored at ^20 °C.
Preparation of Lipid Vesicles Containing 125I-TID-PC
Large unilamellar vesicles (LUVs) of EPC, EPC/PS (3:1, mol/mol), or 
EPC/CL (3:1, mol/mol) were prepared (0.5 mM in phospholipids) by 
extrusion through polycarbonate membranes of 100-nm pore diameter 
(Avestin Inc., Ottawa, Canada). To prepare the LUVs containing 125I- 
TID-PC (200 ^Ci/^mol of phospholipids), the photoreagent was mixed 
with the lipids in chloroform. Lipids in chloroform were mixed, dried 
under a stream of N2, and resuspended in 40 mM Tris, 100 mM NaCl, 50 
mM glutathione (buffer A) by vortexing. Cardiolipin-containing vesicles 
also had 1 mM EDTA included in the buffer A. Then lipid suspensions 
were incubated at 37 °C for 30 min and passed 11 times through the 
polycarbonate filters using a Liposofast extruder system (Avestin).
Photolabeling Analysis of FABP-Membrane Interactions
Experiments were conducted as previously described (36). Briefly, 
120 ^l of 0.5 mM photoreagent-containing LUVs (30 ^Ci/ml) were 
incubated with the 60 ^g of FABP in 200 ^l of buffer A at room tem­
perature for 30 s. In those experiments where oleate was included, we 
employed a 10:1 protein/ligand (mol/mol) ratio, and the protein-ligand 
complex was prepared prior to the incubation with LUVs. After the 
indicated incubation time, mixtures (0.3 ml) in glass cuvettes were irra­
diated for 30 s with a xenon lamp (450 watts) at a distance of 25 cm. As 
a control, the photoreagent-containing LUVs were irradiated prior to 
their mixture with IFABP. After irradiation, 3 volumes of CHCl3/meth- 
anol (2:1) were added and vortexed, and the organic phase was dis­
carded. FABPs were precipitated with 5 volumes of acetone and redis­
solved in 25 ^l of sample buffer for direct analysis by SDS-PAGE (37). 
Following Coomassie Blue staining, gels were dried and exposed to 
X-Omat film (Eastman Kodak Co.) at ^80 °C for different times, 
depending on the amount of radioactivity.
RESULTS
Construction of Mutant Proteins and Comparison of Structural and 
Ligand-binding Properties with Native IFABP—To examine whether 
the primary determinant of the IFABP fatty acid transfer mechanism 
resides in the lysine residues of the helix-turn-helix domain, we under­
took the construction of point mutants that neutralized or reversed the 
charges of the four lysines of the ^-helical domain and one of the lysine 
residues of the ^-barrel. To control for potential alterations in the over­
all folding of the point mutants, molecular modeling, circular dichroism 
spectroscopy, fluorescence quantum yield measurements of bound 
anthroyloxy fatty acid, equilibrium binding affinity of oleate using the 
ADIFAB method, and determination of the relative partition coefficient 
of 12AO between the IFABPs and SUVs were used. A summary of the 
results for these experiments is presented in Table 1.
Conformational energy minimization calculations of the mutant 
IFABPs were performed for both apo and holo forms of the mutant 
proteins and compared with the wild-type protein, which was also sub­
jected to energy minimization. As shown in Table 1, the differences in 
the overall conformational energy of the mutant proteins compared 
with the native IFABP were small, ranging from 0.01 to 1.87%. The 
solvent-accessible surface areas were found to be similar to that calcu­
lated for the native protein, and the mutant apo-IFABP forms also 
showed protein volume values similar to that of the wild-type apo- 
IFABP (Table 2). For the holoproteins, K27I was found to have a 0.42% 
increase in protein volume, whereas all other mutations resulted in 
somewhat lower volumes than the wild type. When the 95% confidence 
limit for the mean areas and volumes is calculated, it is seen that none of 
the individual mutant or wild type values fall outside the limits. This is 
consistent with the absence of significant conformational change due to 
the mutations.
To examine the likely conformation of the portal domain (residues 
24 –33, 54–55, and 73–74), the backbone of the rest of the protein 
(residues 2–22, 35–52, 57–71, and 76 –130) was superimposed, and the 
result for the minimized holo structures showed that little change was 
introduced by the point mutations to the conformation of the protein. 
Table 3 shows the root mean square displacement for the protein's heavy 
atoms, grouped by structural regions. Not surprisingly, relatively larger 
effects were found in the portal regions for the ^-helix mutants and in the 
^-barrel for the K92 mutations. As a comparison, superimposition of min­
imized apo- and holo-IFABPs showed ^3-fold greater root mean square 
displacement than any of the point mutants. Together, these estimations 
suggest that, as anticipated, the point mutations did not change the overall 
protein structure to a great extent.
A one-tailed t test comparing the root mean square displacements of 
the portal and nonportal regions of the protein was performed. Because 
the variance for the different groups of regions is not the same 
(F-test, p ^ 0.01), the t test for unequal variance was used. It shows 
that the portal region displacements exceed the nonportal displace­
ments (p ^ 0.02).
The CD spectrum of the wild-type protein was found to agree in 
shape and intensity with previously published results (4, 38). The
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TABLE 2
Solvent-accessible surface area and protein volume estimations of wild-type and mutant IFABPs
Solvent-accessible surface area (SAS) and protein volume (PV) were determined as described under “Experimental Procedures.”
Protein
SAS PV
Apo Holo Apo Holo
Å2 Å3
Wild type 7033 7075 19,676 20,190
K16I 7030 7028 19,513 18,806
K16E 6986 7013 19,654 19,374
K20I 7066 7027 19,616 19,202
K20E 6979 7031 19,473 19,437
K27I 7046 7013 19,417 20,274
K27E 7125 7068 19,599 19,544
K29I 7016 7019 19,621 18,973
K29E 7160 7168 19,669 19,204
K92I 6984 6986 19,576 19,242
K92E 6994 6998 19,619 19,295
Mean ^ t1⁄2 ^ S.D. 7038 ^ 156 7039 ^ 132 19,585 ^ 220 19,413 ^ 1195
TABLE 3
Average displacement in the superimposition of minimized structures of mutant and wild-type IFABPs
Root mean square displacement (RMSD) in the superimposition of backbone of the nonportal regions of the minimized holo structures of mutant IFABP with the native 
protein.
RMSD
Protein All heavy atoms
(residues 1–131)
Nonportal regions
(residues 2–22, 35–52, 57–71, 76 –130)
Portal regions
(residues 24 –33, 54–55, 73–74)
Å
K16I 0.55 0.53 0.73
K16E 0.6 0.61 0.63
K20I 0.62 0.62 0.69
K20E 0.51 0.46 0.8
K27I 0.51 0.46 0.69
K27E 0.5 0.47 0.61
K29I 0.46 0.43 0.67
K29E 0.52 0.44 0.93
K92I 0.43 0.43 0.35
K92E 0.45 0.47 0.35
Mean ^ t1⁄2 ^ S.D. 0.52 ^ 0.17 0.49 ^ 0.19 0.65 ^ 0.48
Apo- versus holo-WT 1.51 1.44 1.65
mutant IFABP spectra were similar to the wild type protein spectrum, 
with all showing a minimum at 215 nm (not shown). Values of the molar 
ellipticity at 222 nm, ^222, for wtIFABP and the mutant IFABPs are 
shown in Table 1. It is likely that the variability in ^222 for some of the 
mutants is due to slight errors in protein concentrations of the solutions 
rather than conformational changes.
Fluorescence quantum yields (Qf) for the AOFA are used to assess the 
relative hydrophobicity of the environment surrounding the fluoro­
phore (12, 13, 28, 39). The comparison of 12AO Qf values for the mutant 
and native proteins could therefore indicate whether the modifications 
introduced to the native protein may have altered the dielectric envi­
ronment of its binding pocket. We found that the Qf values for the 
mutant proteins were close to those obtained for the wtIFABP (Table 1), 
suggesting that the modification introduced in the ^-helical domain did 
not modify the hydrophobicity of IFABP ligand binding site.
The fluorescent probe ADIFAB, an IFABP covalently modified with 
an acrylodan fluorophore, was used to assess the equilibrium binding 
affinity of the fatty acid oleate. Binding of FA to ADIFAB induces a red 
shift in the acrylodan emission spectrum, and this is used to provide a 
measure of unbound FA in solution (29). Using the known Kd of ADI- 
FAB for a particular ligand (29), equilibrium binding affinities can be 
determined for another protein. The Kd obtained for oleate binding to 
wtIFABP (37 ^ 1nM) is in agreement with those previously determined 
(4, 29). Data for the mutants demonstrated a single binding site with Kd 
values similar to that obtained for the wild type protein (Table 1).
An apparent partition coefficient value was also obtained for each 
protein, describing the relative distribution of 12AO between an FABP 
and EPC-SUVs. This value was determined by adding SUVs containing 
the energy transfer quencher NBD-PC to a solution containing a pre­
formed 12AO-FABP complex. With the successive addition of increas­
ing amounts of the SUVs, a decrease in fluorescence emission was 
observed upon net displacement of fatty acid to the SUVs. Analysis of 
these data, as described under “Experimental Procedures,” showed a 
preferential partitioning of 12AO to the SUVs (Table 1), in agreement 
with previous results (40). The partition coefficients for 12AO distribu­
tion between the mutant proteins and EPC SUVs are very similar to that 
for the wild-type protein. These results indicate that, as for the native 
ligand, oleate, the relative affinity of the mutant proteins for 12AO is 
essentially unchanged compared with the wild-type IFABP. The similar 
Kp values obtained indicated that in the AOFA transfer assays, the same 
protein/SUV ratios as those employed for the wild-type protein, could 
be employed.
Overall, the controls suggest no major alterations in the conforma­
tion and binding site properties of the mutant IFABPs relative to their 
parent wild-type protein. All mutants fold properly and bind a single FA 
molecule in a relatively hydrophobic binding site.
Effect of Vesicle Concentration on AOFA Transfer from FABPs to 
Membranes—The effect of acceptor membrane phospholipid concen­
tration on rates of ligand transfer has been used to distinguish between 
an aqueous diffusion mechanism, where no effect is observed, and a 
collision-mediated mechanism, where the ligand transfer rate is directly 
related to the donor-acceptor collisional frequency and, hence, the ves­
icle concentration (3–5, 8). To distinguish between these transfer mech­
anisms, AOFA transfer from the mutant proteins to model zwitterionic
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FIGURE 2. Effect of acceptor membrane concentration on 12AO transfer from FABPs to zwitterionic SUVs. Final concentrations were 15 ^M FABP with 1.5 ^M 12AO and 150 – 600 
^M EPC-NBD acceptor vesicles. Each panel represents the results of the neutralization (^) and reversion (f) mutants for a specific position, compared with the wild-type IFABP (wI)(F). 
A, K16I and K16E; B, K20I and K20E; C, K27I and K27E; D, K29I and K29E; E, K92I and K92E. The values shown are the mean ^ S.D. from three sets of experiments. Two-tailed paired t-tests 
were used to determine the significant differences for each mutant versus wild-type IFABP for each concentration. p ^ 0.05 (*) and p ^ 0.01 (#) are presented.
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FIGURE 3. Effect of vesicle charge on AOFA transfer from FABPs. Transfer of 1.5 ^M 12AO from 15 ^M wtIFABP (wI) or mutant proteins to 150 ^M EPC/NBD-PC SUV or 150 ^M 
EPC/NBD-PC SUV containing 25 mol % of PS or CL. Results are expressed relative to the transfer rate of 12AO to EPC/NBD-PC SUV. SUVs of different composition are represented by 
bars in black (EPC/NBD-PC SUV), light gray (PS/NBD-PC SUV), and dark gray (CL/NBD-PC SUV). The values shown are the mean ^ S.D. from three sets of experiments. A, transfer from 
^1 mutants. B, transfer from ^2 mutants. Two-tailed paired t-tests were used to determine the significant differences for each mutant versus wtIFABP for each SUV composition. p ^ 
0.05 (*) and p ^ 0.01 (#) are presented. C, transfer from ^-barrel mutants. Transfer rates of 12AO to CL/NBD-PC SUV are expressed relative to the transfer rate of 12AO to EPC/NBD-PC 
SUV. The values shown in C correspond to a single experiment. The absolute rates of FA transfer from the various proteins to 150 ^M EPC, PS, and CL-vesicles are listed, corresponding 
from top to bottom to EPC-, PS-, and CL-containing SUVs respectively.
membranes was examined as a function of increasing SUV concentra­
tion, and results were compared with those for the wild-type IFABP, a 
well characterized example of an FABP with a collisional ligand transfer 
mechanism. Fig. 2 shows the results obtained when constant concen­
trations of these FABP^AOFA donor complexes were mixed with 
increasing concentrations of EPC SUVs. Wild-type IFABP showed an 
almost proportional increase in transfer rates, ranging from 0.56 ^ 0.10 
to 1.69^ 0.17 s^1, to 150 –600 ^M SUV, similar to previous results (3, 
8). All point mutants examined exhibit a nearly proportional increment 
in 12AO transfer rate as a function of vesicle concentration. This sug­
gests that they all maintain the collisional mechanism of FA transfer 
characteristic of the wtIFABP. Nevertheless, the position of the lysine 
modification was important in determining the absolute AOFA transfer 
rates. Transfer rates from the ^1 helical mutants were lower than rates 
from the wild-type IFABP. For both Lys16 and Lys20, a larger impact was 
observed when lysine was substituted with isoleucine (^36%) than the 
substitution for a glutamic acid (^25% decrease). Notably, the neutral­
izations (Lys 3 Ile mutants) in positions 16 and 20 produce exactly the 
same effects, and the same happens with the charge reversals (Lys 3 
Glu mutants) in the same residues.
In contrast to the ^1 helical lysine mutants, the behavior of the two 
lysine residues of the ^2 helix was divergent. The largest impact of any of 
the point mutations was found for the K27I, exhibiting up to a 70% 
decrease in transfer rate to EPC SUV relative to wild type IFABP. In 
contrast, AOFA transfer rates from K29I and K29E mutants were little 
different from those of IFABP.
Nonportal neutralization mutant at position 92 did not show any 
difference compared with the wtIFABP. Surprisingly, reversion of 
the positive charge at the same position (K92E) results in a signifi­
cant increase in AOFA transfer rates compared with those of wtI- 
FABP (Fig. 2E).
Effect of Vesicle Charge on AOFA Transfer from FABPs to Mem­
branes—Changes in the surface charge properties of the acceptor vesi­
cles can also influence ligand transfer rates if electrostatic interactions 
between donor protein and acceptor membranes are involved, whereas 
in the case of aqueous diffusion, characteristics of the acceptor mem­
brane would not be expected to modulate the transfer rate. Fig. 3 shows 
that, as expected from previous studies, the 12AO transfer rate from 
wtIFABP is substantially increased by incorporation of 25 mol % PS or 
CL into EPC/NBD-PC acceptor membranes (4, 8). A 2-fold increase for 
wtIFABP, on average, was observed in the absolute rate of 12AO trans­
fer to PS-containing vesicles, from 0.56 ^ 0.10 to 0.93 ^ 0.05 s^1 for 
transfer to 150 ^M EPC and PS acceptor SUVs, respectively. Incorpora­
tion of negatively charged CL in acceptor phospholipid vesicles resulted 
in a dramatic 8-fold increase in AOFA transfer rate from IFABP relative 
to transfer to zwitterionic vesicles.
Fig. 3A shows the relative transfer rates from wtIFABP and the ^1 
helix mutants to EPC-containing, PS-containing, and CL-containing 
vesicles, normalized to the EPC acceptor for each protein. Overall, point 
mutants of lysine residues in the ^1 helix resulted in modest decreases in 
sensitivity to vesicle negative charge. Incorporation of CL into the 
acceptor vesicles resulted in approximately 3–4-foldincreasesin AOFA 
transfer rate relative to rates to EPC, as compared with the 8-fold stim­
ulation observed for wtIFABP. K16I showed the greatest effect, with 
acceptor membrane CL causing only a 2-fold increase in AOFA transfer 
rate. For transfer to PS-containing membranes, only K16I showed a 
decrease in relative transfer rate.
Point mutations in the ^2 region showed a consistent pattern for 
neutralization versus charge reversal for both of the lysines. Neutraliza­
tion did not induce significant decreases in AOFA transfer rate to either 
PS or CL vesicles, compared with wtIFABP (Fig. 3B). Moreover as for 
wtIFABP, both K27I and K29I showed a significant increase in 12AO 
transfer rate to CL vesicles relative to EPC vesicles. On the other hand, 
reversion mutants showed substantial decreases in AOFA transfer rates 
to PS vesicles and the most dramatic decreases in transfer rates to CL 
vesicles (78% ( p ^ 0.01) for K27E, and 86% for K29E ( p ^ 0.01)) com­
pared with the wild-type protein (Fig. 3B). Indeed, charge reversal 
mutants K27E and K29E showed no significant modification of AOFA 
transfer rates to vesicles of different composition, as confirmed by anal­
ysis of variance ( p ^ 0.05).
Neutralization of Lys92 to isoleucine or conversion to a negatively 
charged glutamate had little effect on the absolute rates of AOFA trans­
fer to membranes or on the sensitivity to negative charge (Fig. 3C).
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FIGURE 4. Photolabeling of apo- and holo-IFABP by incubation with membranes of 
different composition containing 125I-TID-PC. Each panel corresponds to vesicles of 
different composition: EPC-125I-TID-PC (I), PS-125I-TID-PC (II), and CL-125I-TID-PC (III). 
Experiments were conducted as indicated under “Experimental Procedures.” Results of 
one representative experiment of three are presented. SDS-PAGE (A) and autoradiogra­
phy (B) are shown in each panel. Quantification of the radioactive labeling in the autora­
diography was performed using the ImageJ program (developed by the National Insti­
tutes of Health) as described under “Experimental Procedures.” Values were expressed 
relative to the mass of the protein in the SDS-polyacrylamide gel, quantified with the 
same program, and normalized (1.0) to apo-wtIFABP incubated with EPC LUVs. Results 
were 1.34 ^ 0.14 for holo-wtIFABP incubated with EPC LUVs. Incubation with acidic 
vesicles resulted in 1.03 ^ 0.05 and 1.50 ^ 0.08 (PS LUVs) and 1.38 ^ 0.45 and 1.92 ^ 0.37 
(CL LUVs) for apo- and holo-wtIFABP, respectively. Averages of three separate experi­
ments ^ S.D. are shown.
Interaction of Intestinal FABP with Phospholipid Membranes—To 
analyze directly the interaction of FABPs with membranes, we con­
ducted a series of experiments with membranes containing the photo- 
activable reagent 125I-TID-PC. Upon photolysis, the trifluoromethyl 
diazirine group of this reagent is capable of reacting with protein seg­
ments inserted into or in contact with the hydrophobic region of the 
phospholipid membrane. These experiments were conducted to (a) 
determine the effect of the presence of ligand and the charge of the 
membrane on IFABP-membrane interaction and (b) detect specific 
domains and/or residues involved in the IFABP-membrane interaction. 
We examined apo- and holo- IFABP, as well as the helixless IFABP (9) 
and the point mutants K27E and K29E, for their interactions with zwit­
terionic and acidic phospholipid vesicles. Fig. 4 shows a representative 
result of three separate experiments, which suggests that the holo-IF- 
ABP interacts to a 30 and 50% greater extent than the apo-IFABP with 
100% phosphatidylcholine vesicles and vesicles containing 25% PS, 
respectively. This difference between holo- and apoproteins almost dis­
appears when IFABP is incubated with CL-containing vesicles, where 
both apo- and holo-IFABP interact strongly. The results in Fig. 4 also 
demonstrate an ^40% increase in the degree of interaction between 
IFABP and negatively charged vesicles compared with neutral vesicles.
To begin to assess the structural determinants of IFABP interaction 
with membranes, we selected mutants K27E and K29E due to their 
dramatic decrease in sensitivity to negatively charged vesicles in the FA 
transfer assay and examined their interaction with acidic membranes. 
The results in Fig. 5 show only small if any changes in apparent interac­
tions, compared with the wild type protein (Fig. 5I). To examine the 
participation of the entire ^-helical domain in the physical interaction 
with membranes, we used the helixless variant of IFABP, which lacks 
entirely the 17 residues of the ^-helical domain (9). Helixless IFABP 
does not show appreciable labeling either with zwitterionic (not shown)
FIGURE 5. Photolabeling of wild-type FABP, K27E, K29E, and K92E (I) and wtIFABP 
and helixless IFABP (IFABP-HL)(II) by incubation with acidic membranes containing 
125I-TID-PC and 25% CL. Experiments were conducted as indicated under “Experimen­
tal Procedures.” Results of one representative experiment of three are presented. SDS- 
PAGE (A) and autoradiography (B) are shown in each panel. Quantification of the radio­
active labeling in the autoradiography was performed using the ImageJ program 
(developed by the National Institutes of Health) as described under “Experimental Pro­
cedures.” Values are expressed relative to the mass of the protein in the SDS-polyacryl- 
amide gel, quantified with the same program, and normalized (1.0) to wtIFABP incu­
bated with CL-containing LUVs. Results were 0.82 ^ 0.28 for K27E, 1.41 ^ 0.61 for K29E, 
1.33 ^ 0.48 for K92E, and 0.10 ^ 0.17 for helixless IFABP. Averages of three separate 
experiments ^ S.D. are shown.
or acidic vesicles (Fig. 5II), suggesting that interaction of IFABP with 
membranes is diminished when the helical domain is absent.
DISCUSSION
In the present studies, we have examined the effects of eliminating or 
reversing the charge of the IFABP lysine residues in the ^-helical 
domain in order to further understand the structural basis underlying 
the fatty acid transfer mechanism of IFABP. The mutant proteins gen­
erated showed no major structural or ligand-binding differences com­
pared with the wild-type IFABP (Tables 1 and 2). The structural stability 
of the mutant proteins was not unexpected, since point mutations of 
other members of the FABP family have also been shown to be remark­
ably stable (12, 14), and the covalent incorporation of several fluorescein 
moieties into the IFABP structure did not alter its folding and ligand 
binding properties (41). The absence of effects on the ligand binding site 
was also expected, since IFABP lysines are all oriented toward the aque­
ous milieu (22) and do not interact with the ligand located in the binding 
pocket. Instead, they are accessible for interaction with the polar head 
groups of acceptor membrane phospholipids.
Charge neutralization of three of the four Lys residues of the ^-helical 
domain (K16I, K20I, and K27I) decreases the FA transfer rate to zwit­
terionic vesicles, compared with the wild-type protein. K29I, in con­
trast, shows a behavior indistinguishable from the wild type protein. 
Neutralization of lysine 27 (K27I) results in the most dramatic effect, 
decreasing the absolute transfer rate and markedly diminishing the sen­
sitivity to SUV concentration. Modifications in the two Lys residues of 
the ^1 helix induce very similar changes in the FA transfer kinetics. 
Neutralization of residues 16 and 20 decreases the ligand transfer rate to 
EPC-SUVs; however, the charge reversal mutants were less affected. It is 
possible that maintaining the polar face of the ^1 amphipathic helix 
results in a kinetic behavior similar to the wild type, whereas a disrup­
tion of the ^1 amphipathicity, caused by the incorporation of Ile, dis­
rupts the putative protein-membrane interactions.
The dramatic increase in AOFA transfer rate from wild-type IFABP 
to negatively charged CL vesicles was blunted 2– 4-fold for the ^1 helix 
mutants, indicating that loss of each of the positively charged residues 
diminished somewhat the protein's sensitivity to acceptor charge. Thus, 
unlike FA transfer to zwitterionic acceptor membranes, maintaining the 
^1 helix amphipathicity by retaining a charged residue of either sign has 
the same effect on transfer to acidic vesicles as did the disruption of the 
amphipathicity by replacement of a charged residue with an uncharged 
residue. This suggests the importance of the interactions of cationic 
residues with anionic phospholipids. For the ^2-helix, such charge-
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FIGURE 6. Superimposition of rat intestinal FABP and ^2 Lys mutant structures after 
energy minimization based on the IFABP-palmitate complex x-ray crystal structure 
(19) (Protein Data Bank code 2IFB). The protein molecule is oriented to show the 
different orientation of residues in the ^2 helix most clearly. A, residues 24 and 27 have 
been highlighted to show the altered interaction caused by the K27I and K27E mutations 
over the putative ligand portal domain. B, residues 15 and 29 have been highlighted to 
show the likely disruption of the stabilizing salt bridge between them caused by the K29I 
and K29E mutations.
charge interactions appear even more essential for FA transfer proper­
ties. For both K27E and K29E, sensitivity to acceptor vesicle charge is 
almost completely abolished relative to wild-type IFABP, probably dem­
onstrating electrostatic repulsion between the Glu residues and the 
acidic groups in the membrane. In contrast, replacement of the basic 
residues Lys27 and Lys29 with isoleucine resulted in less than a 2-fold 
decrement in the proteins' sensitivity to acceptor negative charge. This 
systematic and significant difference observed for charge reversal com­
pared with neutralization highlights the importance of charge-charge 
interaction of the ^2 helix with membranes and suggests that the 
charged face of the ^2 helix is critical for membrane interactions that 
lead to the dramatic increase in AOFA transfer rates from IFABP to 
anionic membranes.
The higher AOFA transfer rates obtained for the neutralization 
mutants compared with the reversion mutants could also be a conse­
quence of a contribution of Ile in positions 27 and 29 to the hydrophobic 
patch observed in the IFABP tertiary structure; the ^2 hydrophobic 
residues Val25, Val26, and Leu30 point away from the interior of the 
protein, forming the only hydrophobic patch on the protein surface 
(21). We have recently shown that both electrostatic and hydrophobic 
interactions contribute to the collision-mediated FA transfer mecha­
nism for IFABP (16). Thus, an increase in the hydrophobic character of 
the ^2 helix could offset to some extent the loss of the electrostatic 
interactions of Lys27 and Lys29 with acidic membranes.
The ^2 helix is a key structural element of the putative fatty acid 
portal, and forms long range interactions with the ^2 turn between 
strands C and D. The present studies indicate that it is likely to play a 
role in the fatty acid transfer process as well. NMR solution structures of 
the apo and holo forms of IFABP have demonstrated considerably 
greater differences from those initially suggested by crystallographic 
analysis (7). Notably, the distal half of the ^2 helix and the turn between 
^-strands C and D are the regions of the protein that exhibit the largest 
structural differences; both of these portal domain elements were found 
to be more disordered in the absence of bound ligand and to exhibit dimin­
ished long range interactions (7). This suggests that during ligand exit/ 
entry, a conformational change may take place in this region of the protein, 
allowing the fatty acid to pass through the portal. In addition, mutations in 
the ^2 helix and C-D turn of heart FABP and adipocyte FABP were shown 
to alter the rate of AOFA transfer to membranes, further indicating the 
participation of ^2 in collisional transfer of fatty acids (12, 13). For IFABP, 
mutations at lysine 27 show the largest changes in response to both accep­
tor vesicle concentration and charge. Neutralization of lysine 27 markedly 
diminishes the sensitivity to SUV concentration but maintains sensitivity to 
SUV charge, whereas substitution for glutamic acid at position 27 elimi­
nates the sensitivity to charge but maintains some sensitivity to SUV con­
centration, which is probably secondary to diminished protein-membrane 
interactions. In the holoprotein, Lys27 is oriented across the portal, forming 
an interaction with Asn24, which is located at the end of the turn between 
the two helices. In the apoprotein, by contrast, Lys27 points toward the 
exterior of the molecule (21, 22). Substitution of this lysine is likely to mod­
ify the interaction with Asn24 and/or with the polar head groups of the 
phospholipids, thereby contributing to the changes in FA transfer rate 
observed in the present experiments (Fig. 6A).
Lysine 29 is located in one of the most dynamic regions of backbone 
mobility (7). As for Lys27, neutralization of the residue reduced IFABP 
sensitivity to acceptor membrane negative charge; charge reversal 
resulted in a drastic (^85%) loss in sensitivity to CL-containing vesicles. 
Thus, disruption of the basic character of the ^2 helix disrupts the effec­
tive interaction of holo-IFABP with membranes. In contrast to the large 
differences in AOFA transfer rates from Lys29 IFABP mutants to acidic 
vesicles, mutations in the Lys29 position did not produce significant 
changes in transfer rates to zwitterionic vesicles. It is possible that this 
unique behavior may be explained by the existence of side chain inter­
actions. Unlike the other lysines examined, in the native protein, lysine 
29 forms a surface salt bridge with glutamate 15 on the ^1 helix, a highly 
conserved residue in the superfamily of cytosolic lipid-binding proteins 
(21). The salt bridge may help to hold the two helices together, thereby 
maintaining the stability of the helical cap. The role of surface salt 
bridges in local and overall protein stability has been described in other 
proteins (42, 43). A helical cap that lacks the Lys29-Glu15 salt bridge, 
caused by neutralization or reversal of the positive charge, results in an 
altered behavior compared with the rest of the mutants of the ^-helical 
domain, which can be attributed both to the destabilization of the ^-hel- 
ical domain and to the liberation of the Glu15 charge to the aqueous 
medium. This suggestion is supported by energy minimization of the 
K29I and K29E mutant structures, as shown in Fig. 6B.
In contrast to the ^-helix domain lysine mutants, little effect was 
found following modifications of Lys92, present in ^-strand G, with the 
K92I showing AOFA transfer rates identical to those of the wild-type 
IFABP for all conditions examined and K92E substitution resulting in a 
stimulation of AOFA transfer rate identical to that of wild-type IFABP 
upon CL incorporation into acceptor membranes. K92E substitution 
did result in an increase in absolute AOFA transfer rates to zwitterionic 
membranes, however, suggesting that whereas Lys92 is not an essential 
element of the collisional transfer process, the introduction ofa negative 
charge at this position generates the possibility of an additional interac­
tion of this group with the positive charge of the phosphatidylcholine 
head group on the zwitterionic vesicle.
Physical interaction between the IFABP forms and membranes was 
directly investigated by analyzing the radioactive labeling of the protein 
after incubation with a photoactivable reagent, followed by cross-link­
ing photoactivation. Membrane insertion of several proteins has been 
identified using these reagents (36, 44, 48). The results showed that 
native IFABP interacted with membranes in an acceptor vesicle charge- 
and ligand-dependent manner. The dependence on the membrane 
charge is coincident with our transfer experiments, where the AOFA 
transfer rate is increased to acceptor membranes containing negatively 
charged phospholipids. Since the net surface charge of all cytosol-facing 
membranes is believed to be negative, it seems likely that charge-charge 
interactions are the primary driving force for IFABP-mediated FA 
transfer within the cell. It is interesting to note that CL is a relevant 
constituent of the inner and outer mitochondrial membranes (49), and 
its involvement in protein-membrane interactions is well appreciated 
(50). It is possible that the apparently strong interaction and rapid FA 
transfer rates from IFABP to CL-containing membranes could be sug­
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gesting one aspect of its function in FA trafficking to specific metabolic 
pathways. Indeed, the cross-linking results indicate that IFABP interacts 
more strongly with membranes to deliver FA to zwitterionic and PS- 
containing membranes than to extract FA but interacts strongly with 
CL-containing membranes to facilitate FA transfer in both directions. 
As expected (8 –10), the helixless IFABP showed a markedly diminished 
degree of membrane interaction compared with wtIFABP. In contrast, 
cross-linking analysis of the Lys point mutants showed that the interac­
tion of IFABP with membranes is not affected by individual amino acid 
substitutions. These results are not unexpected, since a cooperative 
effect of the lysines appears to be responsible for effective interaction 
with membranes to take place and since no single point mutation com­
pletely abolished the effect of acceptor membrane properties on AOFA 
transfer. It is also important to note that this method may not be sensi­
tive enough to detect small changes in the degree of IFABP-membrane 
interaction.
The interaction of IFABP with membranes appears to be greater for the 
holoprotein than the apoprotein. This suggests the formation of different 
IFABP-membrane collisional complexes for the holo- versus apo-IFABP, 
and is likely reflecting, in part, the conformational differences demon­
strated for apo- and holo-IFABP by solution structures (7, 51).
Previously, we suggested (8, 12, 14) that the collision-based transfer of 
fatty acids from the FABP binding site to model membranes may occur 
in a multistage process, as follows: stage 1, interaction of FABP with the 
acceptor membrane; stage 2, conformational transition of the dynamic 
portal region from the ordered closed state to a more disordered open 
state; stage 3, dissociation of FA from the ligand binding cavity; and 
stage 4, association of the FA with the acceptor membrane. For wild­
type IFABP, stage 1 would be rate-limiting, and the transfer process 
exhibits collisional kinetics. For the helixless protein (9), we hypothe­
sized that step 3 was rate-limiting due to complete elimination of steps 
1 and 2. Based on the present results, we hypothesize that a stable ^1 
helix is necessary for step 1 to occur and that the ^2 helix is of critical 
importance for steps 1 and 2. Modification of either lysine in ^1 resulted 
in a decreased rate of transport that was probably caused by decreases in 
helix stability, decreased interaction with the membrane, or both. For 
mutant K27I in ^2, it appears that step 1 is markedly dampened, prob­
ably reflecting a weak protein-membrane interaction when the acceptor 
membranes are net neutral. When membranes are negatively charged, 
the K27I and K29I mutants in ^2 each demonstrated a 50% decrease in 
sensitivity to this charge, suggesting that the remaining basic residue 
maintained its charge-charge interactions with the acidic acceptors. In 
contrast, the ^2 charge reversal mutants K27E and K29E showed a dras­
tic decrease in sensitivity to membrane charge, probably reflecting 
repulsive effects with negative charges on the membrane that dimin­
ished the strength of the protein-membrane interaction, step 1. Given 
that the side chain of lysine 27 extends over the portal region and that 
the side chain of lysine 29 stabilizes helix 2-helix 1 interactions, it is 
likely that step 2 could be modified when either of these Lys are substi­
tuted with Ile, resulting in a change in the protein-membrane complex 
and/or decrease in the rate of the conformational transition of the 
dynamic portal, thereby causing slower delivery of FA to membranes. 
The present results also suggest that the collisional complex formed in 
step 1 and the conformational transition of step 2 may be different, 
depending on the acceptor vesicle composition. In all experiments to 
date, however, the transfer data are well fit by a single exponential func­
tion, implying that in the case of the Lys point mutants, the rate-limiting 
step is likely to reflect step 1, a specific protein-membrane interaction. 
Thus, we hypothesize that the lysine mutations modify the conforma­
tion of the IFABP-membrane “collisional complex,” resulting in altered 
fatty acid transfer rates. Although there are no tertiary structures yet 
available foran FABP-membrane complex, evidence for conformational 
changes with membrane binding has been obtained using infrared 
reflection-absorption spectroscopy, where we showed that the second­
ary structure of wtIFABP in lipid monolayers differed from its solution 
structure (10). Changes in IFABP structure upon ligand binding, great­
est in the ligand portal region, are also supportive of a conformational 
change (7, 51). Finally, we have shown that fluorescent fatty acid transfer 
from membrane donors to IFABP occurs via membrane-protein interac­
tion; however, modulation of the transfer rate by membrane and solution 
properties was different than for transfer from protein to membrane, 
implying that the collisional complexes for holo-IFABP and apo-IFABP are 
different (40).
In summary, the present results provide support for the multistep 
process of FA transfer from IFABP to membranes and support the 
hypothesis of Hodsdon and Cistola (7) regarding the existence of a por­
tal domain that undergoes conformational changes during FA release. 
Our results suggest that IFABP interactions with vesicles induce this 
conformational change and further indicate the possibility of different 
conformational changes when the protein is delivering ligand to or 
extracting ligand from membranes of different composition.
Acknowledgments—We are grateful to Dr. R. C. Rossi for providing equipment 
for specific kinetic measurements, and we gratefully acknowledge G. Franchini 
for assistance with the CD measurements. The assistance of Rob Muldowney in 
the molecular modeling is also gratefully acknowledged.
REFERENCES
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
15.
16.
17.
26.
27.
28.
Glatz, J. F. C., and van der Vusse, G. J. (1996) Prog. Lipid Res. 35, 243–282
Bass, N. M. (1985) Chem. Phys. Lipids 38, 95–114
Hsu, K. T., and Storch, J. (1996) J. Biol. Chem. 271, 13317–13323
Co  ´rsico, B., Liou, H. L., and Storch, J. (2004) Biochemistry, 43, 3600 –3607
Kim, H. K., and Storch, J. (1992) J. Biol. Chem. 267, 77– 82
Storch, J., and Thumser, E. A. (2000) Biochim. Biophys. Acta 1486, 28–44 
Hodsdon, M. E., and Cistola, D. P. (1997) Biochemistry 36, 1450 –1460
Co  ´rsico, B., Cistola, D. P., Frieden, C., and Storch, J. (1998) Proc. Natl. Acad. Sci. 
U. S. A. 95, 12174 –12178
Kim, K., Cistola, D. P., and Frieden, C. (1996) Biochemistry 35, 7553–7558
Wu, F., Co  ´rsico, B., Flach, C. R., Cistola, D., Storch, J., and Mendelsohn, R. (2001) 
Biochemistry 40, 1976 –1983
Herr, F. M., Matarese, V., Bernlohr, D. A., and Storch, J. (1995) Biochemistry 34, 
11840 –11845
Herr, F. M., Aronson, J., and Storch, J. (1996) Biochemistry 35, 1296 –1303
13. Liou, H. L., and Storch, J. (2001) Biochemistry 40, 6475– 6485
14. Liou, H. L., Kahn, P. C., and Storch, J. (2002) J. Biol. Chem. 277, 1806 –1815 
Thumser, A. E., Tsai, J., and Storch, J. (2001) J. Mol. Neurosci. 16, 143–150 
Co  ´rsico, B., Franchini, G. R., Hsu, K. T., and Storch, J. (2005) J. Lipid Res. 46, 
1765–1772
LiCata, V. J., and Bernlohr, D. A. (1998) Proteins Struct. Funct. Genet. 33, 577–589
18. Di Pietro, S. M., Co  ´rsico, B., Perduca, M., Monaco, H. L., and Santome´, J. A. (2003) 
Biochemistry 42, 8192– 8203
19. Anantharamaiah, G. M., Jones, M. K., and Segrest, J. P. (1993) in The Amphipathic 
Helix (Epand, R. M., ed) pp. 110 –143, CRC Press, Inc., Boca Raton, FL
20. Higuchi, R., Krummel, B., and Saiki, R. K. (1988) Nucleic Acids Res. 16, 7351–7667
21. Scapin, G., Gordon, J. I., and Sacchettini, J. C. (1992) J. Biol. Chem. 267, 4253– 4269
22. Sacchettini, J. C., Scapin, G., Gopaul, D., and Gordon, J. I. (1992) J. Biol. Chem. 267, 
23534 –23545
23. Lee, B., and Richards, F. M. (1971) J. Mol. Biol. 55, 379 – 400
24. Richards, F. M. (1985) Methods Enzymol. 115, 440 – 469
25. Kajander, T., Kahn, P. C., Passila, S. H., Cohen, D. C., Lehtio, L., Adolfsen, W., 
Warwicker, J., Schell, U., and Goldman, A. (2000) Struct. Fold Des. 8, 1203–1214 
Richards, F. M. (1974) Biophys. Bioeng. 82, 1–14 
Richards, F. M. (1971) J. Mol. Biol. 6, 151–176
Storch, J., Bass, N. M., and Kleinfeld, A. M. (1989) J. Biol. Chem. 264, 8708 – 8713
29. Richieri, G. V., Ogata, R. T., and Kleinfeld, A. M. (1994) J. Biol. Chem. 269, 
23918 –23930
30. Massey, J. B., Bick, D. H., and Pownall, H. J. (1997) Biophys. J. 72, 1732–1743
31. Storch, J. (1990) Hepathology 12, 1447–1449
13988 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER 20•MAY 19, 2006
IFABP Helix Lysines and Fatty Acid Transfer
Storch, J., and Kleinfeld, A. M. (1986) Biochemistry 25, 1717–1726
Weber, T., and Brunner, J. (1995) J. Am. Chem. Soc. 117, 3084 –3095
Co  ´rsico, B., Toledo, J. D., and Garda, H. A. (2001) J. Biol. Chem. 276, 16978 –16985
Laemmli, U. K. (1970) Nature 227, 680 – 685
32. Roseman, M. A., and Thompson, T. E. (1980) Biochemistry 19, 439 – 444
33. Huang, C., and Thompson, T. E. (1974) Methods Enzymol. 32, 485– 489
34.
35.
36.
37.
38. Cle´rico, E. M., Peisajovich, S. G., Ceol´ın, M., Ghiringhelli, P. D., and Erma´cora, M. R. 
(2000) Biochim. Biophys. Acta 1476, 203–218
39. Wootan, M. G., Bass, N. M., Bernlohr, D. A., and Storch, J. (1990) Biochemistry 29, 
9305–9311
40. Thumser, E. A., and Storch, J. (2000) J. Lipid Res. 41, 647– 656
41. Frieden, C., Jiang, N., Cistola, D. P. (1995) Biochemistry 34, 2724 –2730
42. Hennig, M., Darimont, B., Sterner, R., Kirschner, K., and Jansonius, J. N. (1995) Struc­
ture 3, 1295–1306
43. Yip, K. S., Stillman, T. J., Britton, K. L., Artymiuk, P. J., Baker, P. J., Sedelnikova, S. E., 
Engel, P. C., Pasquo, A., Chiaraluce, R., and Consalvi, V. (1995) Structure 3,
1147–1158
44. Weber, T., Paesold, G., Galli, C., Mischler, R., Semenza, G., and Brunner, J. (1994) 
J. Biol. Chem. 269, 18353–18358
45. Durrer, P., Gaudin, Y., Ruigrok, R. W. H., Graf, R., and Brunner, J. (1995) J. Biol. Chem. 
270, 17575–17581
46. Durrer, P., Galli, C., Hoenke, S., Corti, C., Gluck, R., Vorherr, T., and Brunner, J. 
(1996) J. Biol. Chem. 271, 13417–13421
47. Vergeres, G., Manenti, S., Weber, T., and Sturzinger, C. (1995) J. Biol. Chem. 270, 
19879 –19887
48. Garner, J., Durrer, P., Kitchen, J., Brunner, J., and Crooke, E. (1998) J. Biol. Chem. 273, 
5167–5173
49. Hovius, R., Lambrechts, H., Nicolay, K., and de Kruijff, B. (1990) Biochim. Biophys. 
Acta 1021, 217–226
50. Schlattner, U., Gehring, F., Vernoux, N., Tokarska-Schlattner, M., Neumann, D., 
Marcillat, O., Vial, C., and Wallimann, T. (2004) J. Biol. Chem. 279, 24334 –24342
51. Hodsdon, M. E., and Cistola, D. P. (1997) Biochemistry 25, 2278 –2290
MAY 19, 2006•VOLUME 281•NUMBER 20 JOURNAL OF BIOLOGICAL CHEMISTRY 13989
Protein-Membrane Interaction and Fatty Acid Transfer from Intestinal Fatty 
Acid-binding Protein to Membranes: SUPPORT FOR A MULTISTEP PROCESS
Lisandro J. Falomir-Lockhart, Lisandro Laborde, Peter C. Kahn, Judith Storch and 
Betina Córsico
J. Biol. Chem.^2006, 281:13979-13989.
doi: 10.1074/jbc.M511943200 originally published online March 21, 2006
Access the most updated version of this article at doi: 10.1074/jbc.M511943200
Alerts: ^
•^ When this article is cited
•^ When a correction for this article is posted
Click here to choose from all of JBC's e-mail alerts
This article cites 50 references, 17 of which can be accessed free at 
http://www.jbc.org/content/281/20/13979.full.html#ref-list-1
